Altimmune Inc (ALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -39,171 | -46,425 | -11,087 | -3,441 | -9,955 |
| Depreciation Amortization | 25,243 | 36,059 | 135 | 142 | 150 |
| Income taxes - deferred | -6,150 | -2,617 | 0 | 62 | 62 |
| Accounts receivable | 344 | -1,949 | 131 | -1,067 | 3,219 |
| Accounts payable and accrued liabilities | 243 | -2,624 | 854 | 130 | -737 |
| Other Working Capital | 6,980 | -8,691 | 1,116 | -505 | 45 |
| Other Operating Activity | 3,121 | 6,033 | 2,498 | 1,464 | -1,257 |
| Operating Cash Flow | $-9,389 | $-20,214 | $-6,353 | $-3,216 | $-8,474 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -961 | -105 | -125 | -79 | -84 |
| Net Acquisitions | N/A | 13,685 | N/A | N/A | N/A |
| Purchase Sale Intangibles | -40 | -54 | -96 | N/A | N/A |
| Other Investing Activity | -40 | 146 | -96 | 0 | 0 |
| Investing Cash Flow | $-1,001 | $13,726 | $-221 | $-79 | $-84 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 1 | N/A | N/A |
| Debt Repayment | N/A | N/A | N/A | -750 | -1,000 |
| Common Stock Issued | 37,426 | 17 | 2 | 973 | 18,825 |
| Other Financing Activity | -4,936 | 15,825 | 4,980 | 0 | -1,092 |
| Financing Cash Flow | $32,490 | $15,841 | $4,983 | $223 | $16,734 |
| Exchange Rate Effect | -50 | 74 | -172 | -2 | -13 |
| Beginning Cash Position | 12,304 | 2,876 | 4,639 | 18,643 | 10,481 |
| End Cash Position | 34,353 | 12,304 | 2,876 | 15,570 | 18,643 |
| Net Cash Flow | $22,050 | $9,428 | $-1,763 | $-3,074 | $8,162 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,389 | -20,214 | -6,353 | -3,216 | -8,474 |
| Capital Expenditure | -975 | -112 | -125 | -87 | -92 |
| Free Cash Flow | -10,364 | -20,327 | -6,478 | -3,303 | -8,566 |